View all newsletters
Receive our newsletter - data, insights and analysis delivered to you

GxP Refresher Training ICH Q8, Q9 and Q10

This eLearning provides an overview of ICH Q8 Pharmaceutical Development, ICH Q9 Quality Risk Management (QRM) and Q10 Pharmaceutical Quality System (PQS). It summarises the key principles and benefits that accrue with the effective and collective implementation of ICH Q8,9 and 10.

Each section concludes with a short quiz to test your knowledge and following successful completion of the course, you will be issued with a certificate.

Key Learning Objectives

The course provides an introduction, followed by a look at ICH Q10, 9 and 8 in turn.

  • ICHQ10 – the module provides a definition of a Pharmaceutical Quality System (PQS) and its’ primary objective. It describes the inputs, processes and outputs of an effective PQS and the trend towards a quality culture, closing out with MHRA and FDA deficiency data and warning letter trends
  • ICH Q9 – Quality Risk Management (QRM) is a systematic process for the assessment, control, communication, and review of risks to product quality. The module provides an overview of a typical QRM process, along with some risk management tools such as risk ranking and filtering, HACCP and FMEA, closing out with industry trends and regulatory observations
  • ICH Q8 – the module provides an overview of the aim of Pharmaceutical Development and the term “Quality by Design”. It displays the various stages of product/process development and the link to ICH Q12 “Technical and Regulatory Considerations for Pharmaceutical Product Lifecycle Management”. It explains the key concepts of Quality Target Product Profile, Critical Quality Attributes, Critical Process Parameters, Design Space and Control Strategy, providing examples of each. It concludes with industry trends and benefits, along with examples of regulatory observations.

For details on how to apply for the course, please contact us via the ‘Make an Enquiry’ button on this page.

NSF Pharma Biotech's CEO Martin Lush recently had a meeting with a CEO to help solve his company’s pain points.
Making a case for good manufacturing practice (GMP) certification of an excipient manufacturer should be a straightforward exercise since the benefits appear so clear cut...
Risk management across a global supply chain has never been a stronger factor in assuring economic success than it is now.
The heart of the European Union (EU) regulation of in vitro diagnostic medical devices (IVDs) lies in allowing market access to IVDs that offer clinical...
NEWSLETTER Sign up Tick the boxes of the newsletters you would like to receive. A weekly roundup of the latest news and analysis, sent every Friday. The pharmaceutical industry's most comprehensive news and information delivered every month.
I consent to GlobalData UK Limited collecting my details provided via this form in accordance with the Privacy Policy
SUBSCRIBED

THANK YOU

Thank you for subscribing to Pharmaceutical Technology